These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 26645890
61. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Kumar D, Shankar S, Srivastava RK. Cancer Lett; 2014 Feb 28; 343(2):179-89. PubMed ID: 24125861 [Abstract] [Full Text] [Related]
62. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism. Liu Y, Zhao Y, Guo L. Mol Cell Endocrinol; 2016 Jan 15; 420():208-16. PubMed ID: 26549689 [Abstract] [Full Text] [Related]
63. MicroRNA‑26a protects vascular smooth muscle cells against H2O2‑induced injury through activation of the PTEN/AKT/mTOR pathway. Peng J, He X, Zhang L, Liu P. Int J Mol Med; 2018 Sep 15; 42(3):1367-1378. PubMed ID: 29956734 [Abstract] [Full Text] [Related]
64. GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines. Durbas M, Horwacik I, Boratyn E, Kamycka E, Rokita H. Int J Oncol; 2015 Sep 15; 47(3):1143-59. PubMed ID: 26134970 [Abstract] [Full Text] [Related]
65. Osthole inhibits proliferation and induces apoptosis in BV-2 microglia cells in kainic acid-induced epilepsy via modulating PI3K/AKt/mTOR signalling way. Du M, Sun Z, Lu Y, Li YZ, Xu HR, Zeng CQ. Pharm Biol; 2019 Dec 15; 57(1):238-244. PubMed ID: 30922159 [Abstract] [Full Text] [Related]
66. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Bitting RL, Armstrong AJ. Endocr Relat Cancer; 2013 Jun 15; 20(3):R83-99. PubMed ID: 23456430 [Abstract] [Full Text] [Related]
67. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro. Zhang H, Chen J, Zeng Z, Que W, Zhou L. Int J Mol Med; 2013 May 15; 31(5):1127-34. PubMed ID: 23503641 [Abstract] [Full Text] [Related]
68. Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis. Qiao S, Zhang W, Jiang Y, Su Y. J Mol Histol; 2023 Dec 15; 54(6):645-654. PubMed ID: 37740843 [Abstract] [Full Text] [Related]
69. Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells. Wang L, Wang C, Jia Y, Liu Z, Shu X, Liu K. J Cell Biochem; 2016 May 15; 117(5):1233-9. PubMed ID: 26460589 [Abstract] [Full Text] [Related]
70. Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway. Raja Singh P, Sugantha Priya E, Balakrishnan S, Arunkumar R, Sharmila G, Rajalakshmi M, Arunakaran J. Mol Cell Biochem; 2017 Mar 15; 427(1-2):69-79. PubMed ID: 28025797 [Abstract] [Full Text] [Related]
71. Sanggenol L Induces Apoptosis and Cell Cycle Arrest via Activation of p53 and Suppression of PI3K/Akt/mTOR Signaling in Human Prostate Cancer Cells. Won YS, Seo KI. Nutrients; 2020 Feb 14; 12(2):. PubMed ID: 32075054 [Abstract] [Full Text] [Related]
72. Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells. Lian X, Gu J, Gao B, Li Y, Damodaran C, Wei W, Fu Y, Cai L. Biochem Biophys Res Commun; 2018 Jan 29; 496(1):70-75. PubMed ID: 29305864 [Abstract] [Full Text] [Related]
73. Salinomycin-induced autophagy blocks apoptosis via the ATG3/AKT/mTOR signaling axis in PC-3 cells. Zhang Y, Li F, Liu L, Jiang H, Jiang X, Ge X, Cao J, Wang Z, Zhang L, Wang Y. Life Sci; 2018 Aug 15; 207():451-460. PubMed ID: 29966607 [Abstract] [Full Text] [Related]
74. MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway. Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z. Aging (Albany NY); 2018 Aug 27; 10(8):2113-2121. PubMed ID: 30153654 [Abstract] [Full Text] [Related]
75. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells. Borges GA, Elias ST, Amorim B, de Lima CL, Coletta RD, Castilho RM, Squarize CH, Guerra ENS. Phytother Res; 2020 Dec 27; 34(12):3311-3324. PubMed ID: 32628350 [Abstract] [Full Text] [Related]
76. Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway. Liu Y, Chen S, Xue R, Zhao J, Di M. Biochem Biophys Res Commun; 2016 Feb 05; 470(2):350-355. PubMed ID: 26780727 [Abstract] [Full Text] [Related]
77. Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells. Yu Z, Chen Y, Liang C. Med Sci Monit; 2019 Nov 12; 25():8534-8543. PubMed ID: 31714902 [Abstract] [Full Text] [Related]
78. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Liu L, Hu X, Cai GY, Lv Y, Zhuo L, Gao JJ, Cui SY, Feng Z, Fu B, Chen XM. Nephrol Dial Transplant; 2012 Jan 12; 27(1):90-100. PubMed ID: 21633095 [Abstract] [Full Text] [Related]
79. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway. Fan HT, Shi YY, Lin Y, Yang XP. Eur Rev Med Pharmacol Sci; 2019 Sep 12; 23(18):7808-7815. PubMed ID: 31599405 [Abstract] [Full Text] [Related]
80. Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. Schwab J, Antonescu C, Boland P, Healey J, Rosenberg A, Nielsen P, Iafrate J, Delaney T, Yoon S, Choy E, Harmon D, Raskin K, Yang C, Mankin H, Springfield D, Hornicek F, Duan Z. Anticancer Res; 2009 Jun 12; 29(6):1867-71. PubMed ID: 19528441 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]